Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas. While multimodal therapies have improved outcomes for low- and intermediate-risk ...
Baritinib is a drug to treat rheumatoid arthritis. After outbreak of COVID-19, Benevolent AI Company discovered that AAK1 is a regulatory factor in the process of SARS-CoC-2 infection by generating a ...
Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease. Published in Translational ...
Neuroscientists at King’s College London (UK) have pinpointed a mechanism behind the increased neural connectivity seen in ...
Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. TxGNN is the first AI model specifically developed to identify ...
Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United States topped $722 billion, a trend that's expected to continue. Yet, nearly 30% ...
A recent study published in the journal Nature Medicine developed TxGNN, a graph-based foundation model for zero-shot drug repurposing. Only 5% to 7% of rare diseases have approved drugs. Expanding ...
In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...
Repurposing and repositioning have gained considerable attention from a range of stakeholders, including NIH, academic institutions, pharmaceutical companies, and even some technology companies, for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results